ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MRKR Marker Therapeutics Inc

3.78
-0.16 (-4.06%)
Last Updated: 12:26:35
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Marker Therapeutics Inc MRKR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.16 -4.06% 3.78 12:26:35
Open Price Low Price High Price Close Price Prev Close
3.86 3.5742 4.01 3.94
more quote information »

Recent News

Date Time Source Heading
2/26/20249:07IHNWFeatured1847 Holdings Engages Spartan Capital to Pursue Spinoff or Strategic Transaction for 1847 Cabinets Inc.
2/26/202407:58EDGAR2Form 8-K - Current report
1/22/202407:30GLOBEMarker Therapeutics Receives Approval from United States..
1/08/202408:30EDGAR2Form 8-K - Current report
1/08/202408:24GLOBEMarker Therapeutics Announces Clinical Program Updates and..
12/21/202311:00GLOBEMarker Therapeutics Announces Participation in Biotech..
12/11/202307:35EDGAR2Form 8-K - Current report
12/11/202307:00GLOBEMarker Therapeutics Announces Sustained Complete Response in..
11/20/202316:37EDGAR2Form 8-K - Current report
11/09/202317:03EDGAR2Form 8-K - Current report
11/09/202317:00GLOBEMarker Therapeutics Reports Third Quarter 2023 Financial..
11/09/202316:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
9/11/202307:10EDGAR2Form 8-K - Current report
9/11/202307:00GLOBEMarker Therapeutics Announces Complete Response in First..
8/30/202308:00GLOBEMarker Therapeutics to Present at the H.C. Wainwright 25th..
8/14/202316:37EDGAR2Form 8-K - Current report
8/14/202316:30GLOBEMarker Therapeutics Reports Second Quarter 2023 Financial..
8/14/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202307:22EDGAR2Form 8-K - Current report
8/07/202307:00GLOBEMarker Therapeutics Reports Non-Clinical Proof-of-Concept..
7/26/202307:00GLOBEMarker Therapeutics to Participate in Virtual Roundtable..
7/10/202307:09EDGAR2Form 8-K - Current report
7/10/202307:00GLOBEEuropean Medicines Agency Grants Orphan Drug Designation for..
7/05/202316:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
7/03/202316:05EDGAR2Form 8-K - Current report
6/30/202316:05EDGAR2Form 8-K - Current report
6/26/202307:00GLOBEMarker Therapeutics Reports MT-401 Non-Clinical Data in AML..
6/12/202307:00GLOBEMarker Therapeutics Announces First Lymphoma Patient Treated..
5/31/202306:30GLOBEMarker Therapeutics Reports Pre-Clinical Data of its MT-601..
5/08/202307:30GLOBEMarker Therapeutics Appoints Monic Stuart, M.D., as Chief..
5/01/202307:30GLOBEMarker Therapeutics Announces Comprehensive Non-Dilutive..
3/22/202308:10GLOBEMarker Therapeutics Reports Fiscal Year 2022 Corporate and..

Your Recent History

Delayed Upgrade Clock